Patient info Open main menu

Setofilm 4 mg orodispersible Films – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
4 mg
Other strengths and forms:
Contains active substance:

Patient leaflet - Setofilm 4 mg orodispersible Films

What Setofilm is and what it is used for

Setofilm contains a medicine called ondansetron. This belongs to a group of drugs called antiemetics.

Setofilm is used to treat and prevent nausea (feeling sick) and vomiting (being sick) caused by chemotherapy or radiotherapy. It can also be used after an operation to prevent and treat nausea and vomiting.

What you need to know before you use Setofilm

Do not use Setofilm

* if you are allergic to ondansetron or any of the other ingredients of this medicine (listed in section 6)

* if you are allergic to other drugs belonging to the group of selective serotonin (5-HT3)-receptor antagonists (eg. granisetron, dolasetron) * if you are taking apomorphine (used to treat Parkinson’s disease). For further information see section "Other medicines and Setofilm".

Warnings and precautions

Talk to your doctor, nurse or pharmacist before taking Setofilm if:

* you have ever had heart problems

* you have an irregular or uneven heart beat (arrhythmia) * you have liver problems

* you have a blockage in your gut or bowel or if you suffer from severe constipation

* you have problems with the levels of salts in your blood, such as potassium, sodium and magnesium

* you are going to have or have recently had your tonsils or adenoids removed, because treatment with Setofilm may hide symptoms of internal bleeding

* this medicine is prescribed for a child below the age of 2 years or with a body surface of less than 0.6m2 and / or weighing 10kg and below * you have depression or other conditions that are treated with antidepressant. The use of these medicines together with Setofilm can lead to serotonin syndrome, a potentially life threatening condition (see “Other medicines and Setofilm”).

If you need to have a blood or urine test, you should tell the person performing the test that you are taking Setofilm.

If you are not sure if any of the above apply to you, talk to your doctor, nurse or pharmacist before taking Setofilm.

Other medicines and Setofilm

Tell your doctor, nurse or pharmacist if you are taking, have recently taken, might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because Setofilm can affect the way some medicines work. Also some other medicines can affect the way Setofilm works.

In particular, tell your doctor, nurse or pharmacist if you are taking any of the following medicines:

Setofilm 4mg Orodispersible Films

(ondansetron)

* Apomorphine (a medical substance for the treatment of Parkinson’s disease), as excessive drop in blood pressure and loss of consciousness have been reported when administering Setofilm (Ondansetron) concomitantly with apomorphine.

* phenytoin, carbamazepine (medicines used to treat epilepsy) * rifampicin (for treating serious bacterial infections, like TB) * antibiotics such as erythromycin

* antifungal agents such as ketoconazole

* tramadol (for managing pain)

* anti-arrhythmics (used to treat irregular or fast heart beat) * beta-blockers (used to treat certain heart or eye problems, anxiety or prevent migraines)

* medicines that can affect the heart (such as haloperidol or methadone) * cancer medicines (especially anthracyclines and trastuzumab) * antidepressants such as SSRIs (selective serotonin reuptake inhibitors) used to treat depression and/or anxiety including fluoxetine, paroxetine, sertraline, fluvoxamine, citalopram, escitalopram; or

* SNRIs (serotonin noradrenaline reuptake inhibitors) used to treat depression and/or anxiety including venlafaxine, duloxetine * Buprenorphine/opioids (medicinal products used for the treatment of pain or dependency on narcotics).

If you are not sure if any of the above applies to you, talk to your doctor, nurse or pharmacist before having Setofilm.

Setofilm with food and drink

You may take Setofilm with food and drink.

Pregnancy, breast-feeding and fertility

Pregnancy:

Only use Setofilm during the first trimester of pregnancy after discussion with your doctor of the potential benefits and risks to you and your unborn baby of the different treatment options. This is because Setofilm can slightly increase the risk of a baby being born with cleft lip and/or cleft palate (openings or splits in the upper lip and/or the roof of the mouth). If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. If you are a woman of childbearing potential you may be advised to use effective contraception.

Breast-feeding:

You should not breast-feed whilst using Setofilm as it can pass into your breast milk.

Fertility:

There is no information on the effects of ondansetron on human fertility.

Driving and using machines

Setofilm has little or no effect on your ability to drive or use machines.

How to use Setofilm

Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor, or pharmacist if you are not sure. Setofilm is for oral use only. It may be recommended for patients who may have problems with taking or swallowing tablets; for example children or elderly.

* Remove Setofilm orodispersible film from each individual sachet taking care not to damage the film as follows: Open the sachet only at the tear tag and tear this off slowly. Do not cut the sachet.

* Before use check the film for damage as you should only use undamaged films.

* Ensure the mouth is empty (and your fingers are dry) before placing Setofilm orodispersible film on to the tongue.

* The film should disintegrate on your tongue without water in a few seconds (in saliva which can be subsequently swallowed).

Treatment and prevention of sickness (nausea and vomiting) in patients receiving chemotherapy or radiotherapy

Elderly:

Setofilm is well tolerated by elderly patients. They may take the same dosage as adults (see below).

Adults:

8 mg 1-2 hours before chemotherapy or radiotherapy, followed by 8 mg every 12 hours for up to 5 days. Your doctor may recommend that your first dose is given by injection.

Children (aged 6 months and over) and adolescents (<18 years): Your doctor will recommend what dose of ondansetron should be given. The individualised dose will depend on the weight or body surface area of the child.

®

Ref: 2037/090124/1/F

1

1

6

4

5

2

2

3

3

(ondansetron)

Patient Information Leaflet (continued)

Prevention and Treatment of post-operative sickness

(nausea and vomiting).

Elderly:

Ondansetron is well tolerated by elderly patients. They may take the same dosage as adults; see below.

Adults:

Take 16 mg of Setofilm 1 hour before your operation or 8 mg administered one hour before your operation, followed by two further doses of 8 mg 8 hours apart as directed by your doctor.

Children aged over 4 years and adolescents:

In children weighing 40 kg and above, take 4mg of Setofilm 1 hour before your operation, followed by one further dose of 4 mg after 12 hours.

Liver dysfunction:

Do not take more than 8 mg of ondansetron daily if your liver does not work properly (moderate to severe liver problems).

If you take more Setofilm than you should

Contact your doctor, or go to the hospital immediately if you or your child have taken more Setofilm than recommended in this package leaflet or than prescribed by your doctor. Take the medicine pack with you.

If you forget to take Setofilm

If you forget to take Setofilm and feel sick or vomit

* Take a dose of Setofilm as soon as possible

* Take your next dose of Setofilm at the usual time

* Do not take a double dose to make up for a forgotten dose

If you miss a dose but do not feel sick or vomit

* Take the next dose

* Do not take a double dose to make up for the forgotten dose

If you stop taking Setofilm

If you feel unwell and stop taking Setofilm tell your doctor or nurse as soon as possible.

If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Some side effects could be serious:

Stop taking Setofilm and immediately contact your doctor or go to the nearest hospital if you or your child experience any of the following:

Allergic reactions:

The signs of an allergic reaction may include:

* Sudden wheezing and chest pain or chest tightness

* Severe itching of the skin

* Skin rash - red spots or lumps under your skin (hives) anywhere on your body

* Swelling of the eyelids, throat, face, lips, tongue or mouth * Difficulty in breathing or swallowing

* Collapse

* Myocardial ischemia:

The signs include:

* sudden chest pain or

* chest tightness

Other side effects include:

Very common side effects (affects more than 1 in 10 people)

* Headache

Common side effects (affects less than 1 in 10 people)

* Sensation of warmth or flushing

* Constipation; tell your doctor, if you have crampy abdominal pain or difficulty in passing stools. They will need to monitor you carefully to see how the treatment is affecting you.

Uncommon side effects (affects less than 1 in 100 people)

* Hiccups

* Low blood pressure, which may make you feel faint or dizzy

* Palpitations (conscious awareness of heart beat) or irregular or slow heart beat

* Chest pain

* Fits (convulsions)

* Unusual unintentional eye or body movements or shaking * Changes to liver function test results (changes are more common if you take ondansetron with a medicine called Cisplatin)

Rare (affects less than 1 in 1,000 people)

* Allergic reactions, sometimes severe, including anaphylaxis * Feeling dizzy or lightheaded [when ondansetron is given intravenously (i.e. through a tube in your vein)]

* Temporary visual disturbances e.g. blurred vision (predominantly when ondansetron is given intravenously)

* Disturbance in heart rhythm and ECG changes, including a special form of heart rhythm disorder called Torsade de Pointes, (sometimes causing sudden loss of consciousness)

Very rare (affects less than 1 in 10,000 people):

* Temporary loss of eyesight, (predominantly when ondansetron is given intravenously) which normally comes back within 20 minutes * A widespread rash with blisters and skin peeling on much of the body surface (toxic epidermal necrolysis)

Reporting of side effects

If you get any side effects, talk to your doctor, nurse or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

How to store Setofilm

Keep the sachet tightly closed in order to protect from moisture. Keep out of the sight and reach of children.

Do not take Setofilm after the expiry date shown on the sachet or carton after EXP. If your doctor tells you to stop using this medicine, take any remaining medicine back to the pharmacist for safe disposal. Only keep this medicine if your doctor tells you to.

If your medicine becomes discoloured or shows any signs of deterioration, ask your pharmacist who will advise you what to do.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

Contents of the pack and other information

What this medicine contains

Each orodispersible film contains 4mg of ondansetron (as base). The other ingredients are: polyvinyl alcohol, macrogol 1000, acesulfame potassium E950, glycerol E422, titanium dioxide E171, rice starch, levomenthol, polysorbate 80 E433.

What this medicine looks like and contents of the pack Setofilm are a white, rectangular (size 3 cm2), orodispersible film. Setofilm comes in packs containing 10 Sachets.

Manufacturer and Licence Holder

This medicine is manufactured by LTS Lohmann Therapie-Systeme AG, Lohmannstrasse 2, D-56626 Andernach, Germany and is procured from within the EU and repackaged by the Product Licence Holder: Lexon (UK) Ltd, Unit 18, Oxleasow Road, East Moons Moat, Redditch, Worcestershire, B98 0RE.

PL 15184/2037 Setofilm 4mg Orodispersible Films

SETOFILM is a registered trademark of Velinor AG.

Revision date: 09/01/24

Blind or partially sighted? Is this leaflet hard to see or read? Phone Lexon (UK) Limited,

Tel: 01527 505414 to obtain the leaflet in a format suitable for you

POM

Ref: 2037/090124/1/B

4

5

6

Setofilm 4mg Orodispersible Films

®

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLPI 15184/2037

Last revision stated in the text: 9 January 2024 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Setofilm 4 mg orodispersible Films

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Ondansetron
Strength 4 mg
Pharmaceutical form Orodispersible film
Setofilm 4 mg Orodispersible Film:
White, rectangular (size 3 cm2), orodispersible film.
How is it taken Oral
Excipients Poly (vinyl alcohol), Macrogol 1000, Acesulfame potassium E950, Glycerol E422, Titanium dioxide E171, Rice starch, Levomenthol, Polysorbate 80 E433
Pack sizes 10 film
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life 3 years.
Storage Keep the sachet tightly closed in order to protect from moisture.
Drug group (ATC)
  1. A Alimentary tract and metabolism drugs
    1. A04 Antiemetics and antinauseants
      1. A04A Antiemetics and antinauseants
        1. A04AA Serotonin (5HT3) antagonists, antiemetics and antinauseants
          1. A04AA01 ondansetron
Marketing authorisation PL 20011/0041 (first authorised 11 May 2010), PLPI 15184/2037
Marketing authorisation holder Norgine Pharmaceuticals Limited
Codes GTIN 5012748009189 · BNF 04060000

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.